A gene (ertx) encoding a putative ARC transporter was cloned from the erythromycin producer Saccharopolyspora erythraea, using PCR. The primers were based on regions of homology from ARC transporters which confer resistance to macrolide antibiotics. While erty encodes a protein with a strong degree of similarity to other macrolide ARC transporters from streptomycetes and staphylococci, it did not confer resistance to erythromycin, tylosin, spiramycin, oleandomycin, josamcin, chalcomycin or midecamycin when subcloned into sensitive streptomycete hosts. Southern blot analysis suggested that erty did not constitute part of the erythromycin gene cluster as identified to date.
Introduction
The best characterised mechanism of resistance to macrolide antibiotics is mediated by methyltransferases, which modify a specific adenine residue of 23s rRNA (A-2058 in Escherichia coii), preventing antibiotic binding Cl]. This mechanism of resistance confers cross resistance to all macrolide, lincosamide and streptogramin type B (MIS) antibiotics which possess overlapping binding sites in 50 S ribosomal l porters capable of mediating resistance to a variety of MLS antibiotics have been found only in the antibiotic-producing streptomycetes and in clinical isolates of staphylococci.
In Streptomyces fradiae, Streptomyces thermotolerans and Streptomyces ambofaciens which synthesise tylosin, carbomycin and spiramycin respectively, ABC transporters conferring resistance specifically to the antibiotic produced have been located within the macrolide biosynthetic gene cluster . These proteins, TlrC (tylosin resistance), CarA (carbomycin resistance) and SrmB (spiramycin resistance) are of similar size (-500 amino acids), possess two ATP-binding domains and exhibit a high degree of sequence conservation [9] . They are structurally and functionally related to two staphylococcal ABC transporters which mediate resistance to macrolides (including erythromycin) and type B streptogramins (MsrA) [lo] or type A streptogramins only (Vga) [ll] . The aforementioned ABC transporters were identified and isolated by their ability to confer resistance to particular antibiotics. In this paper we describe an alternative approach which utilises the polymerase chain reaction and the high degree of sequence conservation of this group of proteins to detect novel ABC transporters from streptomycetes and related bacteria known to produce polyketide/macrolide and other antibiotics.
Materials and methods

Strains and plasmids
The antibiotic producing organisms used in this study are shown in Table 1 . Escherichia coli (K12) substrain TGl was the host for plasmids involved in most cloning and sequencing experiments. The E. coli vectors used for cloning and subsequent manipulations were pUC19 1161 and pBluescript-SK (Stratagene). The shuttle vector pHL623 comprised the Streptomyces plasmid pIJ486 [17] and the E. coli vector pBR322 (H.K. Lindley, 1990, PhD thesis, University of Leeds). 
Streptomyces
strains and Sac. erythraea were grown in YEME (supplemented with 25% sucrose) [17] at 30°C for 48 h with the exceptions of S. albus which was grown in Tryptic Soya Broth (TSB) at 34°C for 24 h and S. fradiae which was grown in YEME (supplemented with 25% sucrose) at 34°C for 48 h.
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Protoplast preparation and transformation of S. lividans and S. albus were carried out using the procedures of Hopwood [17] .
Minimum Inhibitory Concentrations (M1C.s) of antibiotics were determined by plating onto serial dilutions of antibiotic in Tryptic Soya agar. Cultures to be tested were standardised by diluting in 10.3% (w/v) sucrose to give an absorbance reading of 0.2 at 600 nm and inoculated onto plates containing doubling dilutions of antibiotic between 0.5 and 512 pg ml-' using a multi-point inoculator (Denley Ltd.). The MIC of each antibiotic for each organism was recorded as the lowest antibiotic concentration yielding no growth or a barely visible haze as determined with the naked eye. ration of the DNA. The reactions were run for 30 cycles of 95°C for 1 min, 70°C for 1 min, 72°C for 1 min with a final 5 min extension at 72°C.
DNA manipulations
PCR primer design
Since there is such a high degree of conservation between tIrC and carA ( Fig. l) , it was not considered necessary to create degenerate primers. The primer sequences were based on tlrC with two alterations to create restriction sites. The BamHI site at the 5' terminal of carA was incorporated into the forward primer, VlF, and a single base change from C * to G in the reverse strand of the tZrC sequence created a second BamHI site in the reverse primer, V2R (Fig. 11. 
PCR conditions
Each PCR reaction contained 20 pmol of the primers VlF and V2R, 1.5 mM Mg'+, dNTP's (200 PM), 1 ~1 of template DNA at a concentration of 0.5 /.Lg /.L-' and glycerol (20% v/v>. Tag polymerase (20 units) was added after the initial denatuChromosomal DNA was isolated from Streptomyces strains using the following method. A 5-10 ml volume of a mid-exponential culture was centrifuged at 2000 X g for 10 min, the pellet washed twice in 25 mM Tris HCl, pH 8.0 containing 25 mM EDTA and resuspended in 5 ml of the same buffer containing 50 pg ml-' RNase and 20 mg ml-' lysozyme. After incubation at 30 "C for 0.5 h, 500 ~1 of 5 M NaCl was added and vortexed until the suspension became viscous; 1.2 ml of 10% (w/v> SDS was added and the suspension vortexed again until the viscosity was visibly reduced. The lysate was incubated at 65°C for 15 min, cooled to room temperature and 2.4 ml of 5 M potassium acetate, pH 7.0 was added followed by vortexing and chilling on ice for 20 min. Following centrifugation at 4000 X g for 0.5 h, the supernatant was decanted and recentrifuged for 5 min to remove all traces of cell debris. Chromosomal DNA was precipitated by the addition of 5 ml of isopropanol. After 0.5 h at -20°C the DNA was recovered by centrifugation at 4000 X g for 15 min, air dried at room temperature and redissolved in 700 ~1 of 50 mM Tris HCl, pH 8.0 containing 10 mM EDTA. The DNA was reprecipi-tated by the addition of 75 ~1 of 3.0 M sodium acetate, pH 7.0 and 500 ~1 of isopropanol. The DNA was again recovered by centrifugation in a microfuge for 30 s, washed in 80% (v/v) ethanol, vacuum dried and redissolved in 200 ~1 of TE buffer.
PCR fragments were purified using Promega Magic'" PCR Preps and treated with T4 ligase, DNA polymerase KIenow fragment and polynucleotide kinase for 4 h to create concatenated fragments. These were then digested with BamHI and cloned into the corresponding site of pBluescript-SK.
The 5.5 kb BamHI fragment containing the gene of interest was detected by colony hybridization in pBluescript-SK according to the protocol in the Stratagene manual. Similarly, exonuclease deletions were created following the Stratagene protocol. DNA was sequenced by the Sanger di-deoxy method using a Pharmacia T7 sequencing kit.
Computer analyses
DNA sequences were analysed using DNASIS (Pharmacia). Multiple amino acid sequence alignments were carried out using SOMAP [18] and the phylogenetic tree was constructed using CLUSTAL v [19] .
3. Results and discussion
PCR amplification of streptomycete DNA
The DNA sequences of tlrC and carA were accessed from the Leeds OWL composite sequence database [20] and aligned using the SOMAP programme [18] . The regions that coded specifically for the Walker motifs were highly conserved; however, in order to reduce the likelihood of amplifying ABC transporters not associated with antibiotic resistance/transport, primers were designed based on conserved regions flanking the Walker motifs of these two genes. An amino acid motif '-VSHDR/VTHDR-' which lies 20 amino acids beyond the 3' end of the second Walker motif, was found to be highly conserved in TlrC, CarA, SrmB, MsrA, and VgA and not in any other ABC transporter that we analysed such as DrrA or OleC. This region was used to create the reverse primer, V2R. The forward primer, VlF, was based on a region of DNA conservation in the central region of the tlrC and carA, this region, coded for the motif '-IRNAKE-' and was conserved in TlrC, SrmB and CarA.
VlF and V2R, were used to amplify DNA from Sac. erythraea and 10 Streptomyces known to produce polyketide/macrolide antibiotics and other secondary metabolites (Table 1) . Fragments of 600 bp and 250 bp were amplified from S. frudiue and Sac. erythraea DNA respectively and these were cloned into pBluescript to create pMON56 and pERY7. Sequencing of the 600 bp insert of pMON56 confirmed it to be the region of tlrC within the primers. pERY7 was sequenced and the putative ORFs were analysed for possible Walker motifs using the DNA-SIS programme and a Walker motif -B was identified. The amino acid sequence of this small fragment was estimated to have sufficient similarity with the ABC transporters which conferred resistance to MLS antibiotics, therefore it was decided to clone the gene in its entirety.
In addition to the 250 bp fragment from Sac. erythruea, a fragment of approximately 300 bp was amplified from S. coelicolor DNA, one of approximately 300 bp from S. lividans DNA and one of approximately 400 bp from S. antibioticus DNA. These were not investigated further. Amplification products were not obtained from S. albus, S. felleus, S. griseofiscus, S. peuceticus or S. tendae DNAs.
Cloning of a putative ABC transporter from Sac. erythraea
The 250 bp fragment of pERY7 was used to probe chromosomal DNA from Sac. erythraea and was found to hybridize to a 5.5 kb BamHI fragment. DNA from Sac. erythruea was digested with BamHI, ligated into pBluescript and cloned into E. coli TGl. Approximately 300 colonies were screened by colony hybridization (again using the 250 bp fragment as the probe). One colony produced a strong signal and when analysed, was found to contain a 5.5kb BamHI insert. Further analysis of this construct, pMON14, localised the gene of interest on internal 2.2 kb Kpnl and 1.1 kb Sstl fragments (Fig. 2) . The 2.2 kb lclclclclclclclclclcl fragment was then sub-cloned in both orientations in pUC19 to create pUBK2100 and pUBK21OOR.
Sequencing data
A nested set of deletions was created in the 2.2 kb @rI fragment by treating cleaved pUBK2100 and pUBK2lOOR with exonuclease III. The deletion fragments were then cloned in pBluescript and the nucleotide sequence of the 2.2 kb KpnI fragment determined in both directions using a T7 sequencing kit (Pharmacia). Sequence analysis of the 2.2kb KpnI fragment revealed a partial ORF, commencing 450 bp from the 5' KpnI site of pUBK2100. The remaining 3' end of the ORF, including the proposed termination codon, was determined by sequencing and found to lie on the adjoining 250 bp KpnI/SstI fragment (Fig. 2) . The complete ORF was analysed using the DNASIS programme and revealed a protein of 480aa comprising two ATP binding domains. A putative ribosome binding site was also identified 10 bp from the proposed ATG start codon. The gene has been designated ertX (erythraea transporter X) and has been lodged in the EMBL database under accession no. X80735. Comparison of the deduced amino acid sequence of ErtX with other proteins in the Leeds OWL database revealed that it was similar to other ABC transporters, particularly TlrC, SrmB, MsrA, VgA and LmrC a putative ABC transporter, from the lincomycin biosynthesis gene cluster of S. lincolnemis (accession no. X79146); sequence conservation being strongest within the Walker motifs (Fig. 3) . ErtX p ossessed a 37% and 36% sequence identity with TlrC and SrmB respectively but only 26% identity with LmrC. There was a 29% and 26% sequence identity with the staphylococcal ABC transporters VgA and MsrA respectively.
A phylogenetic tree was constructed, based on the neighbour-joining method [21] illustrating the relationship between ErtX and the ABC transporters which confer resistance to macrolides as well as VgA and LmrC (Fig. 4) . The tree shows division into two main branches, the staphylococcal transporters and the transporters from Streptomyces which confer resistance to macrolides. This latter group further sub-divided into those containing the single domain transporters (OleC and DrrA) and those containing two ATP-binding domains (TlrC and SrmB). ErtX was most closely related to these latter proteins. LmrC formed a separate branch, possibly attributable to its potential for interaction with a lincosamide antibiotic (lincomycin).
Characterisation of ErtX
The 5.5 kb BumHI fragment was cloned into the streptomycete shuttle vector pHL623 to create pHMS14 and transformed into S. albus and S. liuiduns. The MICs of erythromycin for both these species bearing pHL623 (control) and pHMSl4 (containing erti) were determined. Strains carrying ertX (pHMS14) did not show any increase in resistance to erythromycin compared to the control strains. In S. albus the MIC remained at 4 pg ml-' and in S. fividans at 8 pg ml-'. The MIC's of tylosin, spiramycin and oleandomycin were also compared in the presence and absence of ertX but again no noticeable increase was observed. Both strains were found to be sensitive to josamycin, chalcomycin and midecamycin irrespective of the presence of ertX when disc-tested with 100 pg ml-' of the antibiotic. While ertX did not confer resistance to any of the antibiotics tested, the idea that it transports an intermediate in erythromycin biosynthesis remains a possibility.
The inability of ertY to confer antibiotic resistance in these heterologous hosts may be due to lack of gene expression. Preliminary RNA studies using RNA slot-blots revealed that while ertX was expressed in 48 h cultures of S. liuiduns (pHMS14), there was no evidence for expression of the gene in similar cultures of S. albus (pHMS14) or Sac. erythraea (data not shown). Clearly further work is required to ensure the reliable expression of ErtX in a variety of hosts. S. albus is the preferred background for the phenotypic characterisation of ertX since this species is fully sensitive to MLS antibiotics whereas the more generally used streptomycete cloning host S. liuidans, has been shown carry a gene encoding a ribosomal methyltransferase which confers MLS resistance [15] .
In Sac. erythraea, antibiotic biosynthesis and resistance genes are generally regarded as being clustered together [22] . Therefore with the aim of localising ertX within the Sac. erythraea genome and particularly to test for its possible involvement in erythromycin biosynthesis/transport, 50 kb of the erythromycin biosynthesis gene cluster was probed with the fragment ery7R (Fig. 2) . The probe did not hybridise to this region indicating that ertX did not constitute part of the erythromycin biosynthesis gene cluster as defined to date (J. CortCs, pers. comm.). However the formal possibility remains that ertX is indeed involved in the erythromycin pathway and that in common with the tylosin resistance gene tlrA of S. frudiue, it is (exceptionally) not part of the biosynthesis gene cluster [23] .
